Real-Time Reverse-Transcription Quantitative Polymerase Chain Reaction Assay Is a Feasible Method for the Relative Quantification of Heregulin Expression in Non–Small Cell Lung Can...

Por Kristof, Jessica, Sakrison, Kellen, Jin, Xiaoping, Nakamaru, Kenji, Schneider, Matthias, Beckman, Robert A, Freeman, Daniel, Spittle, Cindy, Feng, Wenqin
Publicado no Biomark Insights (2017)

Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression

Por Xu, Xu-Zhi, Garcia, Marileila Varella, Li, Tian-yu, Khor, Li-Yan, Gajapathy, R Sujatha, Spittle, Cindy, Weed, Scott, Lessin, Stuart R, Wu, Hong
Publicado em 2009

Sensitivity of plasma BRAF(mutant) and NRAS(mutant) cell‐free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non‐RECIST disease progression

Por Chang, Gregory A., Tadepalli, Jyothirmayee S., Shao, Yongzhao, Zhang, Yilong, Weiss, Sarah, Robinson, Eric, Spittle, Cindy, Furtado, Manohar, Shelton, Dawne N., Karlin-Neumann, George, Pavlick, Anna, Osman, Iman, Polsky, David
Publicado no Mol Oncol (2015)

TERT, BRAF, and NRAS mutational heterogeneity between paired primary and metastatic melanoma tumors

Por Chang, Gregory A., Wiggins, Jennifer M., Corless, Broderick C., Syeda, Mahrukh M., Tadepalli, Jyothirmayee S., Blake, Shria, Fleming, Nathaniel, Darvishian, Farbod, Pavlick, Anna, Berman, Russell, Shapiro, Richard, Shao, Yongzhao, Karlin-Neumann, George, Spittle, Cindy, Osman, Iman, Polsky, David
Publicado no J Invest Dermatol (2020)